Patents Examined by Keith B. MacMillan
  • Method of treatment of arterial and venous thromboembolic disorders
    Patent number: 6056958
    Abstract: This invention relates to a method of prevention and/or treatment of thrombosis in a mammal without significantly altering bleeding time or coagulation. This invention further relates to methods of using selective inhibitors of the binding of vitronectin to the .alpha..sub.v .beta..sub.3 receptor, alone or in combination with other therapeutic agents, for the inhibition of thrombus formation and/or the treatment of thromboembolic disorders.
    Type: Grant
    Filed: July 28, 1997
    Date of Patent: May 2, 2000
    Assignee: Dupont Pharmaceuticals
    Inventor: Shaker Ahmed Mousa